In 33/49 (67%) patients (8 t‐AML and 25 MRC‐AML), TP53 mutation was associated with complex karyotype (CK, 9% of 335 patients evaluated for TP53 mutations). The gene discussed is TP53; the disease is acute myeloid leukemia.